D68.318 – Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
Coding Notes
Active
Billable, valid for HIPAA-covered transactions
Applicable To
Antithromboplastinemia
Antithromboplastinogenemia
Hemorrhagic disorder due to intrinsic increase in antithrombin
Hemorrhagic disorder due to intrinsic increase in anti-VIIIa
Hemorrhagic disorder due to intrinsic increase in anti-IXa
Hemorrhagic disorder due to intrinsic increase in anti-XIa
GEM Conversion to ICD-9 CM
MDC / MS-DRG Reference
Back Reference of Diagnostic Codes
Sibling Codes
Parent Sibling Codes
Codes with Same Suffix
View in Tabular
Code | Title |
---|---|
D50-D89 | Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) |
D65-D69 | Coagulation defects, purpura and other hemorrhagic conditions (D65-D69) |
D68 | Other coagulation defects |
D68.3 | Hemorrhagic disorder due to circulating anticoagulants |
D68.31 | Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors |
D68.318 |
Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
Applicable to
Antithromboplastinemia
Antithromboplastinogenemia
Hemorrhagic disorder due to intrinsic increase in antithrombin
Hemorrhagic disorder due to intrinsic increase in anti-VIIIa
Hemorrhagic disorder due to intrinsic increase in anti-IXa
Hemorrhagic disorder due to intrinsic increase in anti-XIa
|